Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Toxicology

Aluminium

Aluminium

<0.37 umol/L: Normal (no history of CRF).

<2.22 umol/L: Desirable in CRF patients.

>2.22 umol/L: Excessive accumulation.

>3.70 umol/L: Cause for concern, high risk of toxicity in children.

>7.41 umol/L: Urgent action required; High Risk of toxicity in all.

Amfetamine (Amphetamine)

Amfetamine (Amphetamine)

Toxic range: > 0.2 mg/L. Amfetamine concentrations above 0.50 mg/L have been linked to fatalities, but in regular amfetamine users, blood concentrations may range up to 3 mg/L without toxic effects.  (Schulz et al. Critical Care 2012, 16:R136). 

Amitriptyline & Nortriptyline

Amitriptyline & Nortriptyline

In therapeutic use, plasma concentrations for the two drugs combined do not usually exceed 300 ug/L, with symptoms associated with toxicity observed at levels greater than 500 ug/L. (Clarke's Analysis of Drugs & Poisons, Third Edition)

Arsenic (blood)

Arsenic (blood)

Normal values: < 95 nmol/L

Source, Trace Element Laboratories Update 2018

Benzodiazepine Quantiation (Diazepam, Nordiazepam, Temazepam, Oxazepam)

Benzodiazepine Quantiation (Diazepam, Nordiazepam, Temazepam, Oxazepam)

Diazepam: Toxicity associated with concentrations > 3 mg/L.

Nordiazepam: Toxicity associated with concentrations >  1.5 mg/L.

Oxazepam: Toxicity associated with concentrations > 2 mg/L.

Temazepam: Toxicity associated with concentrations > 2 mg/L.
(Schulz et al. Critical Care 2012, 16:R136).

Please contact the laboratory if benzodiazepine measurement is required for therapeutic monitoring purposes.

Bisoprolol

Bisoprolol

Therapeutic range: 0.01 - 0.1 mg/L. (Schulz et al. Critical Care 2012, 16:R136).

Blood Chromium

Blood Chromium

Normal values: <15 nmol/L

MHRA threshold (7ppb) for patients with MoM hip joints: 135 nmol/L

 

Cadmium

Cadmium

Cadmium (blood) (CAD)

nmol/L

Non-smokers

<27

Smokers

<54

Significant Exposure

>90

Source, SAS Trace Element Laboratories Update 2018

 

Citalopram

Citalopram

Citalopram Therapeutic range - 50 - 110ug/L

Desmethylcitalopram may weakly contribute to pharmacological actions.

Please contact the laboratory if citalopram measurement is required for therapeutic monitoring purposes.

Citalopram is measured by LC-MS/MS.

Clobazam

Clobazam

Therapeutic use of clobazam is associated with concentrations of up to 0.4 mg/L. (TIAFT reference blood level list of therapeutic and toxic substances, September 2004).

Clomipramine

Clomipramine

Therapeutic Range: 90 - 250 ug/L.

Analysed by LC-MS/MS 

Toxicity associated with clomipramine levels > 400 ug/L. 

Clomipramine

Clomipramine

Therapeutic Range: 90 - 250 ug/L.

Analysed by LC-MS/MS 

Toxicity associated with clomipramine levels > 400 ug/L. 

Clozapine (Clozaril)

Clozapine (Clozaril)

350 - 600 ug/L (Schulz et al. Critical Care 2012, 16:R136).

Cobalt (whole blood)

Cobalt (whole blood)

Normal values: <10 nmol/L

MHRA Threshold (7ppb) for patients with MoM hip joints: 120 nmol/L

Cocaine & Benzoylecgonine

Cocaine & Benzoylecgonine

Cocaine: Toxic range: > 0.5 mg/L. (Schulz et al. Critical Care 2012, 16:R136)

Codeine

Codeine

Please contact the laboratory if codeine measurement is required for therapeutic monitoring purposes. 

Units ug/L

Copper

Copper

Copper (serum) (CU)

µmol/L

0 – <4 months

1.4 – 7.2

4 – <6 months

3.9 – 17.3

6 months – <9 years

11.1-27.4

9 years – <13 years

11.2-23.7

13 years – 19 years

11.0-22.5

> 19 years

11.0-25.1

Pregnancy: 16 weeks to term

27 - 40

Wilson’s Disease

< 4

(Source: SAS Trace Element Update, 2018)

Cyclizine

Cyclizine

Therapeutic use of cyclizine typically associated with concentrations of up to 0.25 mg/L. Toxicity is generally associated with concentrations > 0.75 mg/L. (Schulz et al. Critical Care 2012, 16:R136)

[12 3 4 5  >>